Available in English
These are the tools that are translated. The rest of the site covers Spanish pharmacy employment law — the collective agreement, salaries, payslips and the job board — and stays in Spanish, because it would not apply to you anyway.
Which tool are you missing?
The first round of clinical tools is done. If something you need at the counter is missing, tell us and we will look at it.
The sources we use
Everything clinical on the site is built from these sources. They are Spanish: the medicines agency, the paediatric association and the pharmacists’ societies. The clinical content they carry is not specific to Spain, but the regulatory parts are — check your own regulator where it matters. Where the AI writes an answer it is marked, with a reminder to check the original.
Frequently asked questions
Are these tools free?
Yes. Everything on the public site is free. A few extras — saving your work, personal alerts — need a free account.
Where does the information come from?
The Spanish medicines agency AEMPS and its CIMA database, Pediamecum from the Spanish Paediatric Association, SEFAC, BOT-PLUS from the General Council of Pharmacists, and e-lactancia from APILAM. Where an answer is written by AI it is marked, with a reminder to check the official Summary of Product Characteristics.
Can I rely on the doses and the interactions?
It is guidance, built from official sources. It NEVER replaces the judgement of a pharmacist or a doctor. Before any clinical decision, check the official Summary of Product Characteristics.
Is everything on the site translated?
No, and this page only lists what is. The clinical tools are translated; the rest of the site is about Spanish pharmacy employment law — the collective agreement, salaries, payslips and the job board — and stays in Spanish, because it would not apply to you anyway.
Can I ask for a new tool?
Yes, please do. There is an open feedback channel — the contact page is in Spanish, but write in English and it gets read. If a suggestion helps pharmacists, it usually makes it onto the roadmap.